Ethical, social, and legal issues surrounding studies of susceptible populations and individuals

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 4, 1997, Pages 837-841

  Soskolne, Colin L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Applied ethics; Biomonitoring; Genetics; Guidelines; Health risks; Human rights; Industrial toxicology; Law; Political ideology; Privacy; Technology

Indexed keywords

BIOLOGICAL MARKER;

BIOLOGICAL MONITORING; CONFERENCE PAPER; ETHICS; GENETIC PREDISPOSITION; HEALTH HAZARD; HUMAN RIGHTS; LAW; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0030829983     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s4837     Document Type: Conference Paper

References (68)

1. Frankel MS. Guidelines/codes of ethics: merging process and content. Sci Total Environ 184:13-16 (1996).
2. ICOH. International Code of Ethics for Occupational Health Professionals. Singapore:International Commission on Occupational Health, 1996.
3. CIOMS. International Guidelines for Ethical Review of Epidemiological Studies. Geneva:Council for International Organizations of Medical Sciences, 1991.
4. CIOMS. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva:Council for International Organizations of Medical Sciences, 1993.
5. Annas G. The bioethics of biomonitoring people for exposure to carcinogens. In: Molecular Dosimetry and Human Cancer: Analytical, Epidemiological, and Social Considerations (Groopman JD, Skipper PL, eds). Caldwell, NJ:Telford Press, 1991;385-399.
6. Ashford NA, Spadafor CJ, Hattis DB, Caldart CC, eds. Monitoring the Worker for Exposure and Disease. Scientific, Legal, and Ethical Considerations in the Use of Biomarkers. Johns Hopkins Series in Environmental Toxicology. Baltimore, MD:Johns Hopkins University Press, 1990.
7. Ashford NA. Policy considerations for human monitoring in the workplace. J Occup Med 28:563-568 (1986).
8. Ashford NA. Medical screening in the workplace: legal and ethical considerations. Semin Occup Med 1:67-79 (1986).
9. Ashford NA. Monitoring the worker and the community for chemical exposure and disease: legal and ethical considerations within the context of the United States. Clin Chem 41:1426-1437 (1994).
10. Atherley G. Human rights versus occupational medicine. Int J Health Serv 13:265-275 (1983).
11. Atherley G, Johnston N, Tannassee M. Biological surveillance: rights conflict with rights. J Occup Med 8:958-965 (1986).
12. Boden L. Genetic testing in the workplace: costs and benefits. In: Molecular Dosimetry and Human Cancer: Analytical, Epidemiological, and Social Considerations (Groopman JD, Skipper PL, eds). Caldwell, NJ:Telford Press, 1991;401-415.
13. Correa P. Molecular and biochemical methods in cancer epidemiology and prevention: the path between the laboratory and the population. Cancer Epidemiol Biomarkers Prev 2:85-88 (1993).
14. Friend SH. Genetic models for studying cancer susceptibility. Science 259:774-775 (1993).
15. Grandjean P, Sorsa M. Ethical aspects of genetic predisposition to environmentally-related disease. Sci Total Environ 184:37-43 (1996).
16. Green J. Detecting the hypersusceptible worker: genetics and politics in industrial medicine. Int J Health Serv 13:247-264 (1983).
17. Hatchwell PK. Genetic research: implications for workplace screening. Occup Health Rev April/May:8-11 (1992).
18. Higginson J, Chu F. Ethical considerations and responsibilities in communicating health risk information. J Clin Epidemiol 44(Suppl 1):51S-56S (1991).
19. Hulka BS, Wilcosky TC, Griffith JD, eds. Biological Markers in Epidemiology. New York:Oxford University Press, 1990.
20. Hulka BS. Overview of biological markers. In: Biological Markers in Epidemiology (Hulka BS, Wilcosky TC, Griffith JD, eds). New York:Oxford University Press, 1990;3-15.
21. Hulka BS. Methodologie issues in molecular epidemiology. In: Biological Markers in Epidemiology (Hulka BS, Wilcosky TC, Griffith JD, eds). New York:Oxford University Press, 1990;214-226.
22. Hulka BS. Epidemiological studies using biological markers: issues for epidemiologists. Cancer Epidemiol Biomarkers Prev 1:13-19 (1991).
23. International Labour Office, Geneva. Workers' Privacy. Part III: Testing in the Workplace. Conditions of Work Digest. Geneva:International Labour Office, 1993;12(2).
24. Jonsen AR. Ethical considerations and responsibilities when communicating health risk information. J Clin Epidemiol 44(Suppl 1):69S-72S (1991).
25. Knoppers BM, Chadwick R. The human genome project: under an international ethical microscope. Science 265:2035-2036 (1994).
26. Lappé M. Ethical issues in testing for differential sensitivity to occupational hazards. J Occup Med 25:797-808 (1983).
27. Lappé M, Gustafson J, Robin R. Ethical and social aspects of screening for genetic disease. N Engl J Med 206:1129-1132 (1972).
28. Lappé M. Ethical concerns in occupational screening programs. J Occup Med 28:572-577 (1986).
29. Loomis D, Wing S. Is molecular epidemiology a germ theory for the end of the twentieth century? Int J Epidemiol 19:1-3 (1991).
30. McMichael AJ. Invited commentary - "Molecular epidemiology": new pathway or new traveling companion? Am J Epidemiol 140:1-11 (1994).
31. Merletti F, Soskolne CL, Vineis P. Epidemiological method applied to occupational health and safety. In: ILO Encyclopedia of Occupational Health and Safety, 4th ed. Geneva:International Labour Office, 1997:28.2-28.6.
32. Neutra RR. What the public can reasonably expect from biomarkers. Health Environ Dig (Freshwater Foundation) 2:3-4 (1988).
33. NRC Committee on Biological Markers. Biological markers in health research. Environ Health Perspect 74:3-9 (1987).
34. Omenn GS. Predictive identification of hypersusceptible individuals. J Occup Med 24:369-374 (1982).
35. Pearce N, de Sanjose S, Boffetta P, Kogevinas M, Saracci R, Savitz D. Limitations of biomarkers of exposure in cancer epidemiology. Epidemiology 6:190-194 (1995).
36. Perera F, Weinstein IB. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chron Dis 35:581-600 (1982).
37. Perera FP. Molecular cancer epidemiology: a new tool in cancer prevention. J Natl Cancer Inst 78:887-898 (1987).
38. Perera FP, Hemminki K, Gryzbowska E, Motykiewicz G, Michalska J, Santella RM, Young T-L, Dickey C, Brandt-Rauf P, DeVivo I et al. Molecular and genetic damage in humans from environmental pollution in Poland. Nature 360:256-258 (1992).
39. Perera FP, Santella R. Carcinogenesis. In: Molecular Epidemiology: Principles and Practices (Schulte P, Perera FP, eds). New York:Academic Press, 1993;277-300.
40. Perera FP. Biomarkers: new tools for studying environmental exposures. Health Environ Dig (Freshwater Foundation) 2:1-3 (1988).
41. Privacy Commissioner of Canada. Genetic Testing and Privacy. Ottawa:Minister of Supply and Services, 1992.
42. Rothman N, Stewart WF, Caporaso NE, Hayes RB. Misclassification of genetic susceptibility biomarkers: implications for case-control studies and cross-population comparisons. Cancer Epidemiol Biomarkers Prev 2:299-303 (1993).
43. Rothstein MA. Medical Screening of Workers. Washington: Bureau of National Affairs, 1984.
44. Sandman PM. Emerging communication responsibilities of epidemiologists. J Clin Epidemiol 44(Suppl 1):41S-50S (1991).
45. Schulte PA. Methodologie issues in the use of biologic markers in epidemiologic research. Am J Epidemiol 126:1006-1016 (1987).
46. Schulte PA, Perera FP, eds. Molecular Epidemiology: Principles and Practices. San Diego, CA:Academic Press, 1993.
47. Schulte PA. Contribution of biological markers to occupational health. Am J Ind Med 20:435-446 (1991).
48. Schulte PA. Ethical issues in the communication of results. J Clin Epidemiol 44(suppl 1):57S-61S (1991).
49. Schulte PA. A conceptual and historical framework for molecular epidemiology. In: Molecular Epidemiology: Principles and Practices (Schulte P, Perera FP, eds). New York:Academic Press, 1993;3-44.
50. Schulte PA, Ringen K. Notification of workers at high risk: an emerging public health problem. Am J Public Health 74:485-490 (1984).
51. Schulte PA, Ringen K, Altekruse EB, Gullen WH, Davidson K, Anderson SS, Patton MG. Notification of a cohort of workers at risk of bladder cancer. J Occup Med 27:19-28 (1985).
52. Shields PG, Harris CC. Molecular epidemiology and the genetics of environmental cancer. JAMA 266:681-687 (1991).
53. Smith PJ. Molecular genetics and human cancer. Med J Aust 158:851-853 (1993).
54. Spivey GH. Health risk communication - a view from within industry. J Clin Epidemiol 44(suppl 1):63S-67S (1991).
55. U.S. Congress. Genetic Monitoring and Screening in the Workplace. OTA-BA-455. Washington:U.S. Government Printing Office, 1990.
56. Vainio H, Husgafvel-Pursiainen K. Editorial: Elimination of environmental factors or elimination of individuals: biomarkers and prevention. J Occup Environ Med 37:12-13 (1995).
57. Van Damme K, Casteleyn L, Heseltine E, Huici A, Sorsa M, van Larebeke N, Vineis P. Individual susceptibility and prevention of occupational diseases: scientific and ethical issues. J Occup Environ Med 37:91-99 (1995).
58. Vineis P. Uses of biochemical and biological markers in occupational epidemiology. Rev Epidemiol Santé Publique 40:S63-S69 (1992).
59. Vineis P, Schulte PA. Scientific and ethical aspects of genetic screening of workers for cancer risk: the case of the n-acetyl-transferase phenotype. J Clin Epidemiol 48:189-197 (1995).
60. Vineis P. Use of biomarkers in epidemiology. The example of metabolic susceptibility to cancer. Toxicol Lett 77:163-168 (1995).
61. Vineis P. Ethical issues in genetic screening of workers. Paper presented at the Collegium Ramazzini, 3-5 November 1995, Washington, DC.
62. Vineis P. Use of biochemical markers in environmental epidemiology. In: Environmental Epidemiology: Exposure and Disease (Bertollini R, Lebowitz MD, Saracci R, Savitz DA, eds). Boca Raton, FL:CRC Lewis, 1996;201-206.
63. Vineis P, Soskolne CL. Cancer risk assessment and management: an ethical perspective. J Occup Med 35:902-908 (1993).
64. Weinstein IB. Molecular cancer epidemiology: the use of new laboratory methods in studies on human cancer causation. In: Epidemiology and Health Risk Assessment (Gordis L, ed). New York:Oxford University Press, 1988;159-165.
65. Wilcosky TC, Griffith JD. Applications of biological markers. In: Biological Markers in Epidemiology (Hulka BS, Wilcosky TC, Griffith JD, eds). New York:Oxford University Press, 1990;16-27.
66. Wyrobek AJ. Male biomarkers of abnormal reproductive outcome. Health Environ Dig 4:1-4 (1990).
67. Occupational Safety and Health Act, July 9, 1970: 91st Congress, 2nd Session. U.S. House of Representatives Report 91-1291:62 pp.
68. Council of Europe. Draft Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Bioethics Convention, and Explanatory Report. Strasbourg:Directorate of Legal Affairs, 1994.